Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA143808
Max Phase: Preclinical
Molecular Formula: C9H5BrINO
Molecular Weight: 349.95
Molecule Type: Small molecule
Associated Items:
ID: ALA143808
Max Phase: Preclinical
Molecular Formula: C9H5BrINO
Molecular Weight: 349.95
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Oc1c(Br)cc(I)c2cccnc12
Standard InChI: InChI=1S/C9H5BrINO/c10-6-4-7(11)5-2-1-3-12-8(5)9(6)13/h1-4,13H
Standard InChI Key: CDGSLUSMMRRKFA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 349.95 | Molecular Weight (Monoisotopic): 348.8599 | AlogP: 3.31 | #Rotatable Bonds: 0 |
Polar Surface Area: 33.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.14 | CX Basic pKa: 3.32 | CX LogP: 3.53 | CX LogD: 3.08 |
Aromatic Rings: 2 | Heavy Atoms: 13 | QED Weighted: 0.74 | Np Likeness Score: -0.42 |
1. Lukovits I, Lopata A.. (1980) Decomposition of pharmacological activity indices into mutually independent components using principal component analysis., 23 (4): [PMID:7381845] [10.1021/jm00178a018] |
Source(1):